Evidence map›Paper›PMID 35872978›Full record

ReviewFrontiers in endocrinology2022

Parathyroid Carcinoma All-In-One, a Rare Life-Threatening Case With Multiple Systemic Manifestations: Case Report and Review of the Literature.

Lorenzo Zelano, Pietro Locantore, Carlo Antonio Rota, Caterina Policola, Andrea Corsello, Esther Diana Rossi, Vittoria Rufini, Luca Zagaria, Marco Raffaelli, Alfredo Pontecorvi

Open access · goldAbstract readCase ReportsReview
In one paragraph

Review in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 20 citations in OpenAlex.

  1. [Coagulation function analysis and postoperative changes in patients with primary hyperparathyroidism].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. The Role of Pomegranate (Food science & nutrition · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Lorenzo ZelanoDepartment of Translational Medicine and Surgery, Unit of Endocrinology, Università Cattolica del Sacro Cuore-Fondazione Policlinico "Gemelli" IRCCS, Rome, Italy.
Pietro LocantoreDepartment of Translational Medicine and Surgery, Unit of Endocrinology, Università Cattolica del Sacro Cuore-Fondazione Policlinico "Gemelli" IRCCS, Rome, Italy.
Carlo Antonio RotaDepartment of Translational Medicine and Surgery, Unit of Endocrinology, Università Cattolica del Sacro Cuore-Fondazione Policlinico "Gemelli" IRCCS, Rome, Italy.
Caterina PolicolaDepartment of Translational Medicine and Surgery, Unit of Endocrinology, Università Cattolica del Sacro Cuore-Fondazione Policlinico "Gemelli" IRCCS, Rome, Italy.
Andrea CorselloDepartment of Translational Medicine and Surgery, Unit of Endocrinology, Università Cattolica del Sacro Cuore-Fondazione Policlinico "Gemelli" IRCCS, Rome, Italy.
Esther Diana RossiInstitute of Pathology, Università Cattolica del Sacro Cuore-Fondazione Policlinico "Gemelli" IRCCS, Rome, Italy.
Vittoria RufiniInstitute of Nuclear Medicine, Università Cattolica del Sacro Cuore-Fondazione Policlinico "Gemelli" IRCCS, Rome, Italy.
Luca ZagariaInstitute of Nuclear Medicine, Università Cattolica del Sacro Cuore-Fondazione Policlinico "Gemelli" IRCCS, Rome, Italy.
Marco RaffaelliDepartment of Endocrine and Metabolic Surgery, Università Cattolica del Sacro Cuore-Fondazione Policlinico "Gemelli" IRCCS, Rome, Italy.
Alfredo PontecorviDepartment of Translational Medicine and Surgery, Unit of Endocrinology, Università Cattolica del Sacro Cuore-Fondazione Policlinico "Gemelli" IRCCS, Rome, Italy.
Università Cattolica del Sacro Cuore · ITIstituti di Ricovero e Cura a Carattere Scientifico · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parathyroid carcinoma (PC) is an extremely rare disease. Although it may occasionally occur in genetic syndromes, it is more often sporadic. It is usually associated with a consistent secretion of PTH, causing severe hypercalcemia and potentially all clinical conditions due to primary hyperparathyroidism. Management of PC can be challenging: some clinical, biochemical, and radiological features may be useful, but the final diagnosis of malignancy strictly relies on histological criteria. To date, radical surgery is the first-choice treatment and is the only effective therapy to control hypercalcemia and other clinical manifestations. On the other hand, chemo- or radiotherapy, local treatments, or novel drugs should be reserved for selected cases. We report an exceptionally unusual case of life-threatening PC, associated with several systemic manifestations: moderate pancreatitis, portal thrombosis, kidney stones, brown tumors, osteoporosis, hungry bone syndrome (HBS), chondrocalcinosis, neuropathy, and depression. The clinical case also represents an opportunity to provide a review of the recent literature, associated with a complete evaluation of the main diagnostic and therapeutic approaches.

Indexed as

HypercalcemiaOsteoporosisParathyroid NeoplasmsHumansbrown tumorshungry bonehypercalcemiaNeuropathypancreatitisparathyroid carcinomasynovitisvenous thrombosis

Identifiers

PMID35872978
PMCPMC9300921
OpenAlexW4284676223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.